Dolores García de Lucas, María <br/><br/>
Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes.  [electronic resource] 

 -  Diabetes research and clinical practice  Apr 2020 
 - 108094 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1872-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2020.108094  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--analysis<br/>Diabetes Mellitus, Type 2--complications<br/>Female<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin, Long-Acting--therapeutic use<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Renal Insufficiency, Chronic--complications<br/>Retrospective Studies<br/>Risk Factors